Summary.-Human and rat normal tissues and tumours have been studied for the presence of toxic substances, possibly of importance in the development of cachexia in patients with cancer and other chronic diseases. The toxic effect of tissue extracts was gauged by measuring the inhibition of growth of mouse L-cells in 1 -ml cultures, as revealed by reduced incorporation of ['4C]leucine into cell protein.
CACHEXIA is frequently seen in patients with advanced cancer (DeWys, 1970; Bodansky, 1975) . In a less pronounced form, the condition may also be seen in patients in whom no organ or function of major importance is directly impaired by the tumour or its metastases (Shapot, 1972) . Although the problem of cachexia is of great importance in the care and treatment of the cancer patient, the underlying metabolic disturbances have received relatively little attention, and they are largely still unexplained. However, several theories have been put forward. It has been suggested that the tumour may have greater affinity than normal tissue for glucose and amino acids, and thus act as a metabolic trap for these important nutrient factors (Wiseman and Ghadially, 1958; DeWys, 1970; Shapot, 1972) . Some tumours produce hormones or hormonelike substances which can have profound * Fellow of the Norwegian Cancer Society.
influence on the metabolism of the host (DeWys, 1970) . It has also been suggested that malignant tumours may generate toxic products with general effect on the host, and toxic substances have in fact been isolated from some malignant tumours and tumour effusions (Nakahara, 1967; Holmberg, 1968) . However, these theories fail to account for the fact that cachexia may also develop in patients with other grave diseases of some duration (DeWys, 1970) .
Evidence has accumulated that toxic substances may be produced during inflammation (Wilhelm, 1973) and immune response (Bloom, 1971; Reed and Lucas, 1975) . Such processes are activated both in neoplastic and non-neoplastic disease. A study was therefore initiated of the presence of toxic factors in malignant as well as non-malignant tissues. Here we wish to report on the purification of a substance which is toxic to cells in culture and which is present in all rat and human tissues tested.
MATERIALS AND METHODS
Cell cultures. Eagle's Minimum Essential Medium with Earle's salts (GIBCO Biocult Ltd., Glasgow, Scotland), 10% calf serum (GIBCO Biocult), 100 ,ug streptomycin/ml and 100 iu penicillin/ml was used throughout. Cell cultures were incubated at 37°C in an atmosphere of 500 CO2 in air.
Mouse L-cells of clone 929 were maintained as monolayer cultures in plastic culture flasks (Falcon, Oxnard, California, U.S.A.) . For test cultures, the cells were trypsinized with a 0.25% trypsin solution, washed once in cell culture medium and adjusted to the desired density in medium.
Unless otherwise stated, test cultures were inoculated with 105 L-cells in a total volume of 1 ml. Included in the 1 ml volume were 0 1 or 0-2 ml test solution, 100 jug gentamycin (Garamycin, Schering Corporation, Kenilworth, New Jersey, U.S.A.) and
inmol) (The Radiochemical Centre, Amersham, England). 1-6 x 10-cm plastic culture tubes (Falcon) were used for all test cultures. In one experiment, HeLa cells and normal rat fibroblasts were used. The HeLa cells were maintained and treated as described for the L-cells, while normal rat fibroblasts were obtained by trypsinization of minced skin and subcutaneous tissue from newborn rats and maintained in culture for 10 days before use in experiments. Experimental conditions with these cell types were as described for the L-cells.
All test cultures were incubated overnight (15-20 h) , and their morphological appearances were evaluated microscopically before harvesting. Bacterial contamination was monitored by microscopy, followed by plating of media aliquots from suspected cultures. In no instance was bacterial growth detected in test cell cultures.
The cultures were washed twice by adding 3 ml phosphate-buffered saline (PBS: 0-14M sodium chloride, OO1M sodium phosphate, pH 7.5) centrifuging at 700 g for 5 min and drawing off the supernatant by suction. The cells were dissolved in 0-1M KOH, followed by precipitation in 100/,, (w/v) trichloroacetic acid. The precipitates were collected on 25-mm glass fibre filters and washed 3 times with 5 ml 10% (w/v) trichloroacetic acid. The filters were transferred to counting vials and dried for 1 h at 95°C. Five ml of toluene-based scintillation liquid was added, and the radioactivity was neasured in a liquid scintillation spectrometer with 70%/ efficiency. Counting time was chosen to give less than 2% counting error for the uninhibited cultures. The resultant coefficient of variation for the incorporation of [14C]leucine into protein in a series of control cultures was less than 30.
Tissues. Walker 256 carcinosarcoma was maintained by transplantation to the axillary region of 6-8-week-old Wistar rats. Tumours were allowed to grow for 14 to 16 days, reaching a diameter of about 2 cm. Normal rat tissues were obtained from animals of the same litters as the tumour-bearing ones.
The rats were killed by cervical dislocation under light ether anaesthesia, and the tumours and normal tissues were removed aseptically. Small necrotic areas were removed from the tumours: those showing more than minimal necrosis were discarded. Human spleen tissue was obtained from patients with Hodgkin's disease undergoing diagnostic laparotomy with splenectomy. Only tissues from histologically normal spleens were used. All tissues were stored under sterile conditions at -20°C until further processing.
Preparation of tissue extracts.-40-60 g of each tissue was minced with scissors and homogenized for 120-180 s (30 s per 10 g of tissue) in 2 volumes of PBS at O°C with an X-1020 homogenizer at 25,000 rev/min (Internationale Laboratoriums-Apparate GmbH, Dottingen, W. Germany). The homogenates were centrifuged at 27,000 g for 30 min at 4°C. The precipitates were discarded. Aliquots of the supernatants were frozen and stored at -20°C for later testing. All operations were done aseptically.
Pressure dialysis-The remaining supernatants were pressure dialyzed with a 1 kg/ cm2 N2 pressure through 30-cm lengths of 1-cm dialysis tubing (Union Carbide Corporation, Chicago, Illinois, U.S.A.). The tubing had previously been boiled and stored in a buffer with 25 mM NaHCO3, 10 mm Na2B40 7 and 10 mm EDTA, pH 9, and was extensively rinsed with distilled water before use. Aliquots of the pressure dialysates were frozen at -20°C for later testing. 45 ml of each pressure dialysate was freeze-dried. The residues in the tubings were discarded.
Gel filtration. Each of the freeze-dried pressure dialysates was dissolved in 2-25 ml water (1/20 of their original volume), giving total volumes of 2-65 to 2-85 ml. Precipitates were removed by centrifugation. Gel filtration of 2-3 ml of each concentrated pressure dialysate was performed on a column of Sephadex G-15 (Pharmacia, Uppsala, Sweden) as described in the legend to Fig. 3 , after the addition of 1 mg Blue Dextran 2000 (Pharmacia) and 0 5 ltCi [L 4,5-3H] counting the 3H activity in 50 ,ul of each fraction. The elution volume of low molecular weight salts from the concentrated pressure dialysates was determined by measuring conductivity with a CDM3 conductivity meter (Radiometer, Copenhagen, Denmark). The fractions indicated by brackets in Fig. 3 were pooled and diluted to 20 ml with PBS. Six ml of each preparation was frozen and stored at -20°C for later testing.
Cation exchange chromatography.-Thie remaining 14 ml of the pooled fractions from gel filtration was loaded on to columns of carboxymethyl cellulose (CM-52, Whatman Biochemicals Ltd., Maidstone, England) equilibrated with PBS. Elution was performed with NaCl gradients as described in the legend to Fig. 5 . The NaCl concentration of the collected fractions w as estimated from the measured conductivity, using a standard curve. The fractions in the range from O-40M to 0-48M NaCl were pooled, as indicated by brackets in Fig. 5 . The pooled fractions were freeze-dried, dissolved in a minimal volume of water, and desalted on a column of Sephadex G-15 in water. A sample of each fraction obtained from the desalting column was applied to a thin layer chromatography (TLC) plate, dried and stained with ninhydrin reagent as described in the section on analytical TLC below. Fractions giving a positive ninhydrin reaction were pooled. Small volumes were removed for analytical TLC. The remaining material was freezedried, redissolved in 2 ml PBS, frozen and stored at -20°C for later testing.
Titration of toxicity. (Fig. 3) . The toxic activity from human spleen appeared in fractions corresponding to a slightly higher molecular weight. The normal abdominal wall preparation showed no inhibitory effect in this system. However, when more of this preparation was added, a moderate inhibition of the test cells was found (Fig. 4) .
In order to rule out the possibility that the reduced cellular incorporation of [14C]leucine into protein was due to (Fig. 3 ). 1-6 12-cm columns of carboxymethylcAlltlose equiilibrated with PBS were loade(d with the poole(d fractions, and elution was performed w7ith linear gradients of NaCl in 10 mMr sodtitum phosphate, pH 7-5, at 0-6 ml/min. Two-ml fractions wvere collected (abscissae (Fig. 3) . In a second control experiment, [3H]thymidine was added as a marker. The cytotoxic effect was eluted well separated from the thymidine (data not shown), ruling out the possibility that the inhibition of cell growth could be due to the presence of thymidine in the extracts.
In the cation exchange chromatography, the cytotoxic activity was eluted with 0-45M NaCL in the case of the Walker tumour, rat liver and human spleen preparations (Fig. 5) . The human spleen in addition gave a second peak of toxic activity which was eluted at 0-55M NaCi. Again, the inhibitory effect of the abdominal wall preparation was not detected in the first instance. However, when larger amounts of the material eluted with 0-45M NaCl was added to the test cell cultures, a slight inhibition was found even with this preparation (Fig. 6) . It is seen that the other preparations gave complete inhibition of protein synthesis, and microscopic examination after incubation overnight showed cell lysis in the inhibited cultures.
The material eluted with 045M NaCl was desalted and subjected to analytical TLC. Fig. 7 . When the toxic fractions from cation exchange chromatography of the human spleen preparation (Fig. 5) were desalted on a Sephadex G-15 column, the toxic material eluted with 0-55m appeared to have a slightly higher molecular weight than the material eluted at 0-45M NaCl. This may explain the fact, pointed out above, that in the gel filtration experiments (Fig. 3) The material is toxic to all cell types tested, as shown in Fig. 8 . However, the HeLa cells are approximately half as sensitive as the other ones.
In attempts to characterize the toxic principle chemically, numerous tests were made for various functional groups. The spots on the TLC plates could be developed by ninhydrin, as indicated above. Furthermore, they could be developed by an o-tolidine/KI reagent after chlorination, indicating the formation of a chloramine (Krebs, Heusser and Wimmer, 1967) . Weak spots in the same position were also developed by a sodium nitroprusside/ acetaldehyde reagent for secondary amines (Krebs et al., 1967) . Tests for carbohydrates, lipids and aromatic or heterocyclic compounds were negative.
Treatment with 6M HCI at 120°C for 96 h gave no hydrolysis, as judged by TLC. Treatment with trypsin, pepsin, papaine, o-chymotrypsin, pronase or RNAse likewise failed to affect the cytotoxicity.
DISCUSSION
In the present work, a cytotoxic substance with mol. wt. approximately 700 daltons has been detected in all human and rat tissues tested. The substance is toxic to all cell types tested in vitro in a concentration of approximately 10-20 /IM, producing cell lysis during incubation overnight. Irrespective of the tissue of origin, its behaviour in ion exchange and TLC experiments is the same, indicating one well-defined substance. In the case of human spleen, there appears to exist also a related second toxic substance of slightly higher molecular weight.
TLC of the purified preparations consistently gave two spots, one of which has been shown to represent toxic material. The other one may represent a derivative of this material. Other contaminating material has not been detected on the TLC plates during the attempts at identification, and it is therefore probable that the toxic substance is reasonably pure.
The tests for various functional groups were largely negative. The few positive results all indicate the presence of amino groups. The extreme resistance of the substance to acid hydrolysis seems to rule out a peptide, leaving an amine as the most probable candidate. However, the possibility cannot be entirely ruled out that this amine-like substance is a nontoxic contaminanit. WAork is now in progress to identify the toxic substance.
The recovery of cytotoxic activity during purification was low in the smallscale experiment described here. Largescale preparations have given considerably better yields, and the low recovery may therefore be due to losses by adsorption during the purification procedure. Furthermore, the similarity of the doseresponse curves of the puirified products (Fig. 6) and those of the pressure dialysates (Fig. 2) indicates that the substance purified is responsible for the toxic activity of the pressure dialysates.
The relationship of the purified substance to the many toxic factors described in the literature is obscure. A few toxic substances have reportedly been isolated from tumour tissue only. Of these, the toxohormone was originally described by Nakahara as a protein, but later it has been suggested that it might be a complex of a protein and a toxic substance of low mol. wt. (Nakahara, 1967) . However, this question does not seem to have been studied further. The cell-growth-inhibiting substance isolated by Holmberg from tumours and tumour effusions was a welldefined peptide (Holmberg, 1968) , and thus has no relation to the present substance. During recent years, several toxic or growth-inhibiting factors from normal tissues or cells in culture have been described. Most of these have originated from research in immunology or growth regulation. Comprehensive reviews of such factors have appeared recently (Bloom, 1971; Lozzio et al., 1975; Reed and Lucas, 1975) . A few of the factors described may be related to the present substance; however, none of them has been reported to be purified to a degree permitting comparison with the substance isolated here.
The amounts of the present toxic substance isolated from different tissues, including tumours, vary by a factor of 3 when related to tissue wet weight. This may indicate that the toxic substance is present in all cells. Possibly it is released during cell death, which can be prominent in tumours (Steel, 1967) and in other diseases. As the substance is toxic to all cell types tested, an influence on the function of cells, e.g. lymphocytes, locally in tumours or other diseased tissue can be anticipated. Another possibility is that the toxic principle is present in specialized cells, such as macrophages, and that it is released from these in immune reactions or during inflammation. These possibilities are now being investigated. Attempts to demonstrate the toxic principle in the circulation of tumour-bearing animals and cancer patients have so far been unsuccessful. The negative results are perhaps not surprising. Due to its low mol. wt., the toxin is probably excreted rapidly through the kidneys. Moreover, in vitro experiments indicate that the toxic substance is absorbed by the target cells. It is therefore probable that the toxin is rapidly removed from the circulation and that hence its concentration in the blood at any time will be very low. The demonstration in the serum may therefore require more sensitive methods than those hitherto used. Further work is in progress to elucidate whether the toxic substance can be absorbed from tumours or other diseased tissues and exert general effects on the metabolism of patients, i.e. play a role in development of cachexia.
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